Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Gains from Investment Securities: 2010-2025

Historic Gains from Investment Securities for Prestige Consumer Healthcare (PBH) over the last 4 years, with Sep 2025 value amounting to $162,000.

  • Prestige Consumer Healthcare's Gains from Investment Securities rose 422.58% to $162,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year decrease of 11.52%. This contributed to the annual value of $5.8 million for FY2025, which is 5.88% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Gains from Investment Securities of $162,000 as of Q3 2025, which was down 96.00% from $4.1 million recorded in Q2 2025.
  • Prestige Consumer Healthcare's 5-year Gains from Investment Securities high stood at $6.6 million for Q1 2021, and its period low was $16,000 during Q4 2022.
  • Moreover, its 3-year median value for Gains from Investment Securities was $4.1 million (2025), whereas its average is $3.1 million.
  • Examining YoY changes over the last 5 years, Prestige Consumer Healthcare's Gains from Investment Securities showed a top increase of 422.58% in 2025 and a maximum decrease of 30.12% in 2025.
  • Prestige Consumer Healthcare's Gains from Investment Securities (Quarterly) stood at $2.9 million in 2021, then skyrocketed by 86.90% to $16,000 in 2022, then climbed by 1.06% to $5.5 million in 2023, then rose by 5.32% to $31,000 in 2024, then skyrocketed by 422.58% to $162,000 in 2025.
  • Its last three reported values are $162,000 in Q3 2025, $4.1 million for Q2 2025, and $31,000 during Q3 2024.